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Abstract 
Recent advances in supportive care and
progress in the development and use of
chemotherapy have considerably improved the
prognosis of many children with malignancy,
thus the need for intensive care admission and
management is increasing, reaching about
40% of patients throughout the disease course.
Cancer remains a major death cause in chil-
dren, though outcomes have considerably
improved over the past decades. Prediction of
outcome for children with cancer in Pediatric
Intensive Care Unit (PICU) obviously requires
clinical guidelines, and these are not well
defined, as well as admission criteria. Major
determinants of negative outcomes remain
severe sepsis/septic shock association and res-
piratory failure, deserving specific approach in
children with cancer, particularly those receiv-
ing  a bone marrow transplantation. A nation-
wide consensus should be achieved among
pediatric intensivists and oncologists regard-
ing the threshold clinical conditions requiring
Intensive Care Unit (ICU) admission as well
as specific critical care protocols. As demon-
strated for the critically ill non-oncologic child,
it appears unreasonable that pediatric patients
with malignancy can be admitted to an adult
Intensive Care Unit ICU. On a national basis a
pool of refecence institutions should be identi-
fied and early referral to an oncologic  PICU is
warranted. 
Introduction
Cancer remains a major death cause in chil-
dren, though outcomes have considerably
improved over the past decades.1-3 Outcomes
for children diagnosed with cancer have
changed since ’70 from 80% mortality to 80%
survival;2 while children with solid tumors 5-
year survival has been reported as 67%, cure
rates for childhood leukemia now approach
90%.4,5 Moreover, hematopoietic stem cell
transplantation (HSCT) indications are still
expanding for both malignant and non-malig-
nant diseases. 
Some of the improvement in survival has
been linked to more aggressive cancer treat-
ment regimens. However, these protocols are
associated with an increase in complications
and life-threatening events that may require
PICU admission. As a consequence, cancer
therapy advances have resulted in an
increased need for critical care services for
these children. Intensive care itself can cause
unavoidalble complications, the most promi-
nent of which are infections that result from
treatment-associated immunosuppression.
Eventually, nearly 40% of pediatric cancer
patients require intensive care services,
accounting for approximately 3% of all PICU
admissions.6,7
Recently, a 3-year (2003-2005) nationwide
italian (involving 27 institutions) survey,
regarding the outcomes of cancer children out-
lined respiratory failure and severe sepsis/sep-
tic shock as major risk factors for cancer-relat-
ed ICU mortality (M.Piastra, unpublished
data). Globally, 1367 patients were enrolled, of
whom 464 medical (non-postoperative)
patiens; PICU survival was about 71.5%, with
substantial differences among different criti-
cal illnesses. Before these data become avail-
able, national survival rates for PICU cancer
patients were not known. In the past decades
reported survival rates ranged from almost
100% mortality in patients requiring prolonged
mechanical ventilation to 100% survival in
those receiving uncomplicated postoperative
care; therefore, concerns arose regarding the
futility of treating critically ill cancer patients.8-11
In fact, the few published studies on the out-
come of children with malignancies who were
admitted to PICU reported poor outcomes,
especially for those requiring ventilatory sup-
port or inotropic support in the context of sep-
sis or after bone marrow transplant.12,13
Nevertheless, recent studies have demonstrat-
ed promising outcomes with an overall survival
rate of >80% in paediatric cancer patients
admitted to a PICU.6,14 Furthermore, great
efforts have been undertaken to assess the risk
of mortality and outcome in paediatric cancer
patients.15
Taking into consideration recent italian epi-
demiological data, an effort has been under-
taken in order to develop and disclose PICU
admission criteria for onco-hematological chil-
dren. Based on main causes, baseline sugges-
tions are being offered aimed at early referral
of critically ill patients affected by systemic
infections and respiratory failure.
Severe sepsis/septic shockpatients
For severe sepsis-septic shock the observed
mortality remains still high, and consistently
higher than recently reported for the italian
non-oncologic pediatric population: namely
55% in the above mentioned italian survey.16
International sepsis guidelines advocate a
timely approach to cardiovascular derange-
ments in septic patients, involving early moni-
toring of hemodynamic status for patients with
fluid-refractory shock. Self-reported data evi-
denced that advanced continuous hemodynam-
ic monitoring has been reported by a minority
of institutions in the 2003-2005 survey. A lim-
ited use of invasive monitoring in children and
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infants should not be longer accepted, given
the possibility of accurate and safer echo-guid-
ed techniques even in younger infants.17
According to recent international guidelines,18
hemodynamic monitoring should guide the
management of critically ill children very early
after ICU admission: the rapid identification of
the hemodynamic pattern and – as a conse-
quence -preload/vasoactive combination thera-
py tailoring can really influence the mortality
from sepsis also in cancer children. 
The timely identification of sepsis towards
severe sepsis-septic shock shift and the early
ICU referral of these patients is of mainstem
importance. The widespread use of vasoactive
agents outside an ICU setting should be dis-
couraged, lacking appropriate hemodynamic
monitoring; conversely, educational programs
should be implemented in order to improve
early circulatory status diagnosis. Both nonin-
vasive Doppler devices and bedside basic
echocardiography can be introduced,  having
an acceptable learning curve - thereby increas-
ing diagnostic accuracy yet in the non-inten-
sive setting.
PICU referral of severely hypotensive (late
referral) patients should be prevented;
patients with unexplained tachycardia (having
ruled out fever and agitation) and early dias-
tolic blood pressure decrease or signs of hypop-
erfusion (including increasing negative Base
Excess or hyperlactacidemia) are more likely
to benefit from PICU admission (Table 1).
Acute respiratory failure 
A recent review paper on pediatric oncology
patients requiring conventional respiratory
support outlined current outcomes both in
Bone Marrow Transplantation (BMT) and non-
BMT children,19 while encouraging clinical
research regarding both NIV and new inter-
faces suitable for pediatric use, Long-term sur-
vival after even prolonged mechanical ventila-
tion in PICU has  been reported. Very recently,
an italian pediatric experience20 seems to con-
firm the role of NPPV in immunocompro-
mised/cancer children affected by early Acute
Respiratory Ditress Syndrome (ARDS), as yet
demonstrated and well established in adults.21-
24 In this feasibility study we reported that 56%
of immunocompromised children with ARDS,
deemed to require conventional invasive venti-
lation, could be successfully managed with
Non invasive Positive Pressure Ventilation
(NPPV),  avoiding endotracheal intubation and
possibly related complications.20 Children suc-
cessfully ventilated with NPPV also showed a
shorter PICU and hospital stay, a lower inci-
dence of  septic complications, including
Ventilator Associated Pneumonia (VAP) and
septic shock. Notably, at PICU admission
severity scores and organ failures did not differ
between the NPPV-success and failure groups.
As a whole, these data strongly suggest that a
NPPV trial should be considered in immuno-
compromised children with early Acute Lung
Injury (ALI) and ARDS. 
Moreover, recent data from a randomized
trial seems to sustain an even earlier introduc-
tion of noninvasive ventilatory support. In his
paper, VM Ranieri and his coworkers highlinght
the importance of very early Continous Positive
Airway Pressure (CPAP) introduction: this
study demonstrates that early use of CPAP in
the hematological ward in immunosuppressed
patients with hematological malignancy, but
without a secure diagnosis of infection, may
prevent evolution of respiratory symptoms to
acute lung injury requiring ventilatory support
and ICU admission.25 These experiences should
be confirmed even in childhood, but it seems
that  a similar rationale exists.  Based on these
data and the available scientific evidence, an
erlier CPAP introduction in respiratory dis-
tressed patients should be encouraged, com-
pared to previous recommendations. The intro-
duction of CPAP within the pediatric oncology
setting represents an interesting option that
can be performed provided that i) a continuous
gas exchange monitoring can be guaranteed; ii)
both medical and non-medical caregivers have
been specifically trained iii) a regular supervi-
sion and timely intervention by pediatric ICU
team can be offered. Previously,  respiratory
parameters threshold had been identifyied for
PICU referral (or respiratory support introduc-
tion, depending on the setting): the association
of SatO2 ≥92% while on 0.30 FiO2 has been sug-
gested. By the  light of recent evidences, it
seems that every respiratory change (in associ-
ation with chest film alterations) including
Respiratory Rate increase by 30% and SatO2
<92% on room air should be investigated and
early CPAP implementation considered. We
actually agree with such a more interventional
attitude, thus we will increasingly offer CPAP
for hypoxaemic H&O patients  than simple oxy-
gen support  in the future.
Pediatric oncology intensivecare specificity
As recently demonstrated, intensive care
outcomes can be very different outside a pedi-
atric-devoted ICU:  in fact, a suboptimal out-
come of children in general adult ICUs in Italy
is suggested by this analysis.26 Interestingly,
the time frame is overlapping with our epi-
demiological study (2003-2005), involving
patients from 27 italian ICUs (21 PICUs and 6
general ICUs) . As a general rule, some reluc-
tance or unjustified delay in treating pediatric
oncology critically ill patients can be present in
general ICUs. Again, a strong rationale  sup-
porting the centralisation of critically ill chil-
dren to PICUs exist, particurlarly in the setting
of pediatric oncology. In fact, early
invasive/noninvasive hemodynamic and venti-
latory support may really impact on the out-
come of the cancer pediatric patient.  Patients
should be rapidly referred – based on pediatric
intensivist’s opinion- from areas lacking spe-
cialised pediatric intensive care. Recent
advances in pediatric oncology clearly require
a high-level critical care as a part of the thera-
peutic program. Therefore, a network of spe-
cialised oncology critical care institutions
should be identifyied on a national basis.
Case Report
Table 1. Organ failure signs triggering Intensive Care Unit  team assessment and possi-
bly Intensive Care Unit  admission/treatment in H&O pediatric patient.
Organ/System Failure PICU admission parameters
Respiratory failure 30% increase basal RR, SatO2 < NIV introduction also in
92% on room air, CXR and clinical signs extra-intensive
setting (subintensive, 
respiratory unit)
Severe sepsis Haemodynamic compromise signs according to age: threshold values
Diastolic BP Systolic BP Heart Rate   
Infant 53 mmHg 72 mmHg 180
Preschool 53 mmHg 7 mmHg 160
School 57  mmHg 83 mmHg 140
Adolescent 66  mmHg 90 mmHg 125
Neurologic compromise GCS <12  or > 3 points variation from baseline; relapsing seizures
Kidney failure Fluid overload, oliguria,  electrolyte derangements, CRRT (all)
Liver failure Severe hypocoagulability, liver support, hepatic enkephalopathy
BP, blood pressure; CRRT,  continuous renal replacement therapy; CXR, chest X-rays; GCS, glasgow coma scale; NIV, non invasive ventilation;
RR, respiratory rate
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